Results Healthcare advises MSD Animal Health on the divestment of its Segré, France facility to TriRx

  • Service: Divestments
  • Sector: Healthcare
  • Sub Sector: CROs & CMOs, Pharma & Biotech
  • Engagement Type: Sell Side
Sep 2020
has divested its Segré, France manufacturing facility to

We are excited to welcome the Segré team to the TriRx family and to partner with MSD Animal Health to continue to provide important products to the market.

Timothy C. Tyson

Chairman & CEO of TriRx

Sector Related Deals

Jan 2022
has divested its API manufacturing site in Cramlington, UK, to
Nov 2021
has made an investment in
company name confidential
Aug 2021
has been acquired by
an Odyssey Investment Partners-backed company
Jun 2021
has acquired a drug product manufacturing facility from
May 2021
has been acquired by
a Behrman Capital-backed company
May 2021
has formed a strategic alliance with
Mar 2021
has licensed the patents and know-how to its Crystalomics Formulation Technology to
Feb 2021
has been acquired by
Jan 2021
has invested in